|Organic compounds -- part of the class 532-570 series patents - Monitor Patents|
USPTO Class 540 | Browse by Industry: Previous - Next | All
01/2009 | Recent | 13: May | Apr | Mar | Feb | Jan | 12: Dec | Nov | Oct | Sep | Aug | July | June | May | April | Mar | Feb | Jan | 11: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 10: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | | 09: Dec | Nov | Oct | Sep | Aug | Jl | Jn | May | Apr | Mar | Fb | Jn | | 2008 | 2007 |
Organic compounds -- part of the class 532-570 series January recently filed with US Patent Office 01/09Below are recently published patent applications awaiting approval from the USPTO. Recent week's RSS XML file available below.
Listing for abstract view: USPTO application #, Title, Abstract excerpt,Patent Agent. Listing format for list view: USPTO National Class full category number, title of the patent application. 01/29/2009 > patent applications in patent subcategories. recently filed with US Patent Office
20090030195 - 1-(2h)-isoquinolone derivative: wherein X represents an aryl group or heteroaryl group which may be substituted, Cy represents a 4- to 7-membered monocyclic heterocyclic ring or a 8- to 10-membered condensed heterocyclic ring which may be substituted, and Z represents O, S, or NRa; or a prodrug thereof; or a pharmaceutically acceptable salt... Agent: Browdy And Neimark, P.l.l.c. 624 Ninth Street, Nw01/22/2009 > patent applications in patent subcategories. recently filed with US Patent Office
20090023914 - Process for preparing drospirenone and intermediate thereof: The present invention encompasses processes for preparing drospirenone and intermediates thereof.... Agent: Kenyon & Kenyon LLP
20090023915 - Process for the preparation of faropenem: The present invention is related to processes for the preparation of faropenem.... Agent: Ranbaxy Inc.
20090023916 - Tetrazine-based bio-orthogonal coupling reagents and methods: Coupling reactions, suitable for use in organic or aqueous media, are performed by contacting a 1,2,4,5-tetrazine with a dienophile. The dienophile may be covalently bonded to a protein, and the coupling reaction may be performed in biological media such as those containing cells or cell lysates. The reactions may be... Agent: Ratnerprestia
20090023917 - Selective estrogen receptor modulators for the treatment of vasomotor symptoms: The present invention relates to a selective estrogen receptor modulator of formula I or Ia: (I) (Ia); or a pharmaceutical acid addition salt thereof; useful for treating vasomotor symptoms, in particular hot flashes, night sweats and other symptoms that affect women around menopause.... Agent: Eli Lilly & Company01/15/2009 > patent applications in patent subcategories. recently filed with US Patent Office
20090018328 - Phthalocyanine compound and method for producing the same, and coloring composition containing the phthalocyanine compound: in the above general formula (1), M represents a divalent to tetravalent metal atom or two hydrogen atoms, and rings A1, A2, A3 and A4 each independently represents a benzene ring or a structure represented by the above general formula (2), provided that at least one of rings A1, A2,... Agent: Westerman, Hattori, Daniels & Adrian, LLP
20090012287 - Process for producing penam compound: An object of the invention is to provide an industrially advantageous process capable of remarkably suppressing the generation of an undesirable by-product cepham compound to thereby efficiently produce a desired 2α-methyl-2β-[(1,2,3-triazol-1-yl)methyl]penam-3α-carboxylic acid ester. In the present invention, a diphenylmethyl 2β-bromomethyl-2α-methylpenam-3α-carboxylate (BMPB) is reacted with 1,2,3-triazole in a halogenated hydrocarbon solvent... Agent: Posz Law Group, PLC
20090005555 - Titanyl phthalocyanine processes and photoconductors thereof: A process which includes treating, mixing, or contacting a Type I titanyl phthalocyanine with a weak acid with a pKa of at least equal to or greater than about 0; dissolving the acid treated Type I titanyl phthalocyanine in a solution of a trihaloacetic acid and an alkylene halide; adding... Agent: Patent Documentation Center
20090005556 - Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2,3-b] [1,5]benzodiazepine: Disclosed is a process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine. The process comprises of reacting 2-(2-aminoanilino)-5-methylthiophene-3-carbonitrile with N-methyl piperazine in conjunction with N-methylpiperazine acid salt, to produce 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine. Also disclosed is a process for obtaining the Polymorphic Form I of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine by crystallizing the crude 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine... Agent: Darby & Darby P.C.Previous industry: Organic compounds -- part of the class 532-570 series
Next industry: Organic compounds -- part of the class 532-570 series
RSS FEED for 20130516:
Integrate FreshPatents.com into your RSS reader/aggregator or website to track weekly updates.
For more info, read this article.
Thank you for viewing Organic compounds -- part of the class 532-570 series patents on the FreshPatents.com website. These are patent applications which have been filed in the United States. There are a variety ways to browse Organic compounds -- part of the class 532-570 series patent applications on our website including browsing by date, agent, inventor, and industry. If you are interested in receiving occasional emails regarding Organic compounds -- part of the class 532-570 series patents we recommend signing up for free keyword monitoring by email.
FreshPatents.com Support - Terms & Conditions
Results in 0.233 seconds